Table 1.
Comparison of baseline demographics, etiological classification of stroke and clinical outcome between tapered and non-tapered occlusion groups.
| Overall (n = 131) | Tapered (n = 31) | Non-tapered (n = 100) | P-value | |
|---|---|---|---|---|
| Age | 50.9 ± 13.9 | 50.6 ± 12.6 | 50.9 ± 14.3 | 0.901 |
| Sex | ||||
| • Male | 107(81.7%) | 26(83.9%) | 81(81.0%) | 0.718 |
| Baseline NIHSS | 14.7 ± 7.2 | 10.3 ± 6.2 | 16.1 ± 7.0 | < 0.001 |
| Risk Factors | ||||
| • HTN | 77(58.8%) | 20(64.5%) | 57(57.0%) | 0.458 |
| • DM | 53(40.5%) | 13(41.9%) | 40(40.0%) | 0.848 |
| • Dyslipidemia | 29(23.0%) | 6(20.0%) | 23(24.0%) | 0.653 |
| • AF | 26(23.9%) | 4(16.0%) | 22(26.2%) | 0.294 |
| • CHF | 7(5.3%) | 0(0.0%) | 7(7.0%) | 0.130 |
| • TIA | 10(7.6%) | 2(6.5%) | 8(8.0%) | 0.777 |
| • Smoking | 18(13.7%) | 4(12.9%) | 14(14.0%) | 0.877 |
| Thrombolysis given | 78(59.5%) | 15(48.4%) | 63(63.0%) | 0.148 |
| TOAST Classification | < 0.001 | |||
| • ICAS | 35(26.7%) | 17(54.8%) | 18(18.0%) | |
| • Cardioembolic | 46(35.1%) | 5(16.1%) | 41(41.0%) | |
| • Undetermined | 50(38.2%) | 9(29.0%) | 41(41.0%) | |
| Good long term outcome ≤ 2(n = 112) | 57(50.9%) | 12(50.0%) | 45(51.1%) | 0.921 |